GB9315467D0 - Sustained release compositions - Google Patents

Sustained release compositions

Info

Publication number
GB9315467D0
GB9315467D0 GB939315467A GB9315467A GB9315467D0 GB 9315467 D0 GB9315467 D0 GB 9315467D0 GB 939315467 A GB939315467 A GB 939315467A GB 9315467 A GB9315467 A GB 9315467A GB 9315467 D0 GB9315467 D0 GB 9315467D0
Authority
GB
United Kingdom
Prior art keywords
sustained release
release compositions
compositions
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB939315467A
Other versions
GB2281204A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GB9315467A priority Critical patent/GB2281204A/en
Publication of GB9315467D0 publication Critical patent/GB9315467D0/en
Priority to IL10994494A priority patent/IL109944A/en
Priority to SG1996009186A priority patent/SG50706A1/en
Priority to ES94304144T priority patent/ES2124372T5/en
Priority to AT94304144T priority patent/ATE172376T1/en
Priority to DE69414046T priority patent/DE69414046T3/en
Priority to EP94304144A priority patent/EP0636370B2/en
Priority to DK94304144T priority patent/DK0636370T4/en
Priority to CZ19941550A priority patent/CZ287918B6/en
Priority to SK763-94A priority patent/SK280534B6/en
Priority to NZ260883A priority patent/NZ260883A/en
Priority to IN571MA1994 priority patent/IN183742B/en
Priority to FI943141A priority patent/FI114285B/en
Priority to PL94304062A priority patent/PL179282B1/en
Priority to NO942470A priority patent/NO306449B1/en
Priority to AU66105/94A priority patent/AU6610594A/en
Priority to CA002127166A priority patent/CA2127166C/en
Priority to HU9402007A priority patent/HU220075B/en
Priority to JP15121994A priority patent/JP3647897B2/en
Priority to KR1019940015740A priority patent/KR100365572B1/en
Publication of GB2281204A publication Critical patent/GB2281204A/en
Priority to US08/843,571 priority patent/US5879705A/en
Priority to AU52995/98A priority patent/AU722358B2/en
Priority to US09/264,399 priority patent/US6143328A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
GB9315467A 1991-12-24 1993-07-27 Sustained release morphine compositions Withdrawn GB2281204A (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB9315467A GB2281204A (en) 1993-07-27 1993-07-27 Sustained release morphine compositions
IL10994494A IL109944A (en) 1993-07-01 1994-06-08 Sustained release dosage unit forms containing morphine and a method of preparing these sustained release dosage unit forms
SG1996009186A SG50706A1 (en) 1993-07-01 1994-06-09 Sustained release compositions and a method of preparing pharmaceutical compositions
ES94304144T ES2124372T5 (en) 1993-07-01 1994-06-09 SUSTAINED RELEASE COMPOSITIONS CONTAINING MORPHINE.
AT94304144T ATE172376T1 (en) 1993-07-01 1994-06-09 MORPHINE-CONTAINING MEDICINAL COMPOSITIONS WITH DELAYED RELEASE
DE69414046T DE69414046T3 (en) 1993-07-01 1994-06-09 Morphine-containing medicinal compositions with delayed drug delivery
EP94304144A EP0636370B2 (en) 1993-07-01 1994-06-09 Sustained release compositions containing morphine
DK94304144T DK0636370T4 (en) 1993-07-01 1994-06-09 Deposits containing morphine
CZ19941550A CZ287918B6 (en) 1993-07-01 1994-06-23 Orally administered unit dosage form with controlled release and process for preparing thereof
SK763-94A SK280534B6 (en) 1993-07-01 1994-06-23 Sustained release preparations of morphine and a method of preparing the same
IN571MA1994 IN183742B (en) 1993-07-27 1994-06-29
NZ260883A NZ260883A (en) 1993-07-01 1994-06-29 Oral sustained-release medicaments containing morphine
FI943141A FI114285B (en) 1993-07-01 1994-06-30 Process for preparing sustained release pharmaceutical dosage unit form
PL94304062A PL179282B1 (en) 1993-07-01 1994-06-30 Retarded release compositions and method of obtaining such compositions
NO942470A NO306449B1 (en) 1993-07-01 1994-06-30 Orally administered morphine preparation for sustained release as well as preparation of multiparticulates for use in the preparation
AU66105/94A AU6610594A (en) 1991-12-24 1994-06-30 Sustained release compositions and a method of preparing pharmaceutical compositions
CA002127166A CA2127166C (en) 1993-07-01 1994-06-30 Sustained release morphine compositions and a method of preparation
KR1019940015740A KR100365572B1 (en) 1993-07-01 1994-07-01 Sustained-release and pharmaceutical compositions
HU9402007A HU220075B (en) 1993-07-01 1994-07-01 Retarde pharmaceutical compositions containing morphine and process for producing them
JP15121994A JP3647897B2 (en) 1993-07-01 1994-07-01 Sustained release unit dosage form
US08/843,571 US5879705A (en) 1993-07-27 1997-04-18 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
AU52995/98A AU722358B2 (en) 1991-12-24 1998-02-06 Sustained release compositions and a method of preparing pharmaceutical compositions
US09/264,399 US6143328A (en) 1993-07-27 1999-03-08 Sustained release compositions and a method of preparing pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9315467A GB2281204A (en) 1993-07-27 1993-07-27 Sustained release morphine compositions

Publications (2)

Publication Number Publication Date
GB9315467D0 true GB9315467D0 (en) 1993-09-08
GB2281204A GB2281204A (en) 1995-03-01

Family

ID=10739462

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9315467A Withdrawn GB2281204A (en) 1991-12-24 1993-07-27 Sustained release morphine compositions

Country Status (2)

Country Link
GB (1) GB2281204A (en)
IN (1) IN183742B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284760B (en) * 1993-11-23 1998-06-24 Euro Celtique Sa A method of preparing pharmaceutical compositions by melt pelletisation
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (en) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
US7192966B2 (en) 2002-11-15 2007-03-20 Branded Products For The Future Pharmaceutical composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
ZA836627B (en) * 1982-10-08 1984-05-30 Verex Lab Constant release rate solid oral dosage formulation of pharmaceutical compounds having a high degree of water solubility
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
WO1992001446A1 (en) * 1990-07-20 1992-02-06 Aps Research Limited Sustained-release formulations
FR2665357B1 (en) * 1990-07-31 1995-03-31 Aiache Jean Marc PROCESS FOR THE PREPARATION OF A BIO-ADHESIVE GALENIC FORM AND GALENIC FORM THUS PREPARED.

Also Published As

Publication number Publication date
IN183742B (en) 2000-04-01
GB2281204A (en) 1995-03-01

Similar Documents

Publication Publication Date Title
GB2253348B (en) Sustained release compositions
PL315128A1 (en) Anti-pollutant compositions
IL110665A0 (en) Erection-inducing compositions
ZA947572B (en) Contraceptive compositions
AU5939394A (en) Sustained release compositions
EG23934A (en) Poroxetine controlled release compositions
GB9318641D0 (en) Compositions
GB9302130D0 (en) Cleasing composition
GB9323313D0 (en) Clenasing compositions
GB9313274D0 (en) Composition
SG47815A1 (en) Cable-making compositions
GB9315467D0 (en) Sustained release compositions
GB9409835D0 (en) Compositions
GB2281914B (en) Composition
GB9313759D0 (en) Cementiferous compositions
GB2282385B (en) Composition
GB9315223D0 (en) Intumescent compositions
GB9403922D0 (en) Sustained release compositions
GB9002442D0 (en) Sustained release compositions
GB9314206D0 (en) Compositions
GB9304400D0 (en) Pharmaceuticla compositions
GB9306033D0 (en) Compositions
GB9306937D0 (en) Anaestetic compositions
GB9309658D0 (en) Delayed release formulations
ZA931972B (en) Release composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)